PAUL A FRIEDMAN Insider Trading $PRLD Prelude Therapeutics Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL A FRIEDMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL A FRIEDMAN. PAUL A FRIEDMAN is Chief Executive Officer in INCYTE CORP ($INCY) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Executive Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Cerulean Pharma Inc. ($CERU) and Director in Verastem, Inc. ($VSTM) and Director in Prelude Therapeutics Inc ($PRLD).
PAUL A FRIEDMAN in Prelude Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 347,522 shares
Latest Transaction: Jun 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL A FRIEDMAN in Prelude Therapeutics Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, DARE, INCY, SNTA, PRLD, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 31.02 | 23,344 | 724,131 | 23,344 | |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 152,576 | 0 | 0 | |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 295,794 | 0 | 0 | |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | P | 0.00 | 76,288 | 0 | 152,576 | |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 152,576 | 0 | 500,098 | 347.5 K to 500.1 K (+43.90 %) |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 295,794 | 0 | 347,522 | 51.7 K to 347.5 K (+571.83 %) |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 152,576 | 0 | 0 | |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 295,794 | 0 | 0 | |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | P | 0.00 | 76,288 | 0 | 152,576 | |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 152,576 | 0 | 500,098 | 347.5 K to 500.1 K (+43.90 %) |
| Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 295,794 | 0 | 347,522 | 51.7 K to 347.5 K (+571.83 %) |
Page: 1